Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry

American Journal of Veterinary Research

Volumn 68, Issue 4, 2007, Pages 405-410

  Gaines, Patrick J ^a   Powell, Timothy D ^a,c   Walmsley, Scott J ^a   Estredge, Kevin L ^a   Wisnewski, Nancy ^a   Stinchcomb, Dan T ^a,c   Withrow, Stephen J ^b   Lana, Susan E ^b  

^a HESKA CORPORATION   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c Inviragen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD SAMPLING; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER SUSCEPTIBILITY; CHROMATOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC TEST; DOG; FEMALE; MALE; MONITORING; NONHUMAN; SCREENING; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; LYMPHOMA, B-CELL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CANIS FAMILIARIS;

EID: 34247548338     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.4.405     Document Type: Article

References (18)

1. Vail DM, MacEwen GE, Young KM. Canine lymphoma and lymphoid leukemias. In: Withrow SJ, MacEwen GE, eds. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders Co, 2001;558-590.
2. Alaiya A, Al-Mohanna M, Linder S. Clinical cancer proteomics: promises and pitfalls. J Proteome Res 2005;4:1213-1222.
3. Veenstra TD, Conrads TP, Hood BL, et al. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics 2005;4:409-418.
4. Petricoin EF, Zoon KC, Kohn EC, et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 2002;1:683-695.
5. Westermeier R, Marouga R. Protein detection methods in proteomics research. Biosci Rep 2005;25:19-32.
6. Low TY, Seow TK, Chung MC. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002;2:1229-1239.
7. Mirgorodskaya E, Braeure C, Fucini P, et al. Nanoflow liquid chromatography coupled to matrix-assisted laser desorption/ionization mass spectrometry: sample preparation, data analysis, and application to the analysis of complex peptide mixtures. Proteomics 2005;5:399-408.
8. Xiao Z, Prieto D, Conrads TP, et al. Proteomic pattern: their potential for disease diagnosis. Mol Cell Endocrinol 2005;230:95-106.
9. Peticoin EF, Liotta LA. SELDI-TOF based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 2004;15:24-30.
10. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.
11. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-3613.
12. Forterre S, Ralia J, Schweigert FJ. Protein profiling of urine from dogs with renal disease using ProteinChip analysis. J Vet Diagn Invest 2004;16:271-277.
13. Forterre S, Raila J, Kohn B, et al. Protein profiling of organic stone matrix and urine from dogs with urolithiasis. J Anim Physiol Nutr (Berl) 2006;90:192-199.
14. Hu J, Coombes KR, Morris JS, et al. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic 2005;3:322-331.
15. Villanueva J, Phillip J, Chaparro CA, et al. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res 2005;4:1060-1072.
16. Moshkovskii SA, Serebryakova MV, Kuteykin-Teplyakov, et al. Ovarian cancer marker of 11.7 kDa detected by proteomics is serum amyloid A1. Proteomics 2005;5:3790-3797.
17. Anderson LN, Anderson NG. The human plasma proteome: history character, and diagnostic prospects. Mol Cell Proteomics 2002;11:845-867.
18. LaBaer J. So, you want to look for biomarkers (introduction to the special biomarkers issue). J Proteome Res 2005;4:1053-1059.